AHR and obesity due to melanocortin 4 receptor deficiency: In line with the theme of this Special Issue on AHR biology, we hope to portray a discrete pathway via which early toxicological studies of TCDD provided the rationale for exploiting the AHR as a therapeutic target in obesity.